Liquid Biopsies, What We Do Not Know (Yet)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liquid Biopsies, What We Do Not Know (Yet)

Published:2017-02 Issue:2 Volume:31 Page:172-179
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Bardelli Alberto,Pantel Klaus

Funder

European Community's Program

European Community‘s Horizon 2020 Program

IMI

Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per mille 2011 Ministero della Salute

AIRC 2010 Special Program Molecular Clinical Oncology 5 per mille

GOI-Merck's

European Research Council Advanced Investigator

European Research Council

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference77 articles.

1. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy;Alix-Panabières;Cancer Discov.,2016

2. A community-based model of rapid autopsy in end-stage cancer patients;Alsop;Nat. Biotechnol.,2016

3. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer;Antonarakis;N. Engl. J. Med.,2014

4. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics;Arteaga;Cancer Cell,2014

5. Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer;Azad;Clin. Cancer Res.,2015

Cited by 406 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atomic force microscopy as a nanomechanical tool for cancer liquid biopsy;Biochemical and Biophysical Research Communications;2024-11

2. Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma?;Discover Oncology;2024-09-11

3. Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers;Frontiers in Oncology;2024-09-10

4. Liquid biopsy: An arsenal for tumour screening and early diagnosis;Cancer Treatment Reviews;2024-09

5. Minimal Residual Disease Testing for Classical Hodgkin Lymphoma: A Comprehensive Review;Critical Reviews in Oncology/Hematology;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3